Navigation Links
Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome
Date:7/21/2014

RG-012 and RG-101 and with respect to the nomination of a third microRNA candidate for clinical development), the projected timeline of clinical development activities, and expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics and biomarkers being discovered and developed by Regulus.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  These and other risks concerning Regulus' financial position and programs are described in additional detail in Regulus filings with the Securities and Exchange Commission.  All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Regulus Therapeutics Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
2. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
3. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
4. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
5. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
6. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
7. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
8. Regulus Appoints Mark G. Foletta to its Board of Directors
9. Regulus to Present at Two Upcoming Investor Conferences
10. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
11. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ... "Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials ... This is first time in history, Chinese ... multi-center clinical trials of drugs in ... implemented on March 1, 2015. The guidance provides ...
(Date:5/22/2015)... -- Richmond Pharmacology is a university ... worldwide reputation for excellence in clinical trials. It ... reviewed medical journals. Its officers are engaged with ... about rules for transparency and publication of clinical ... Clinical research is conducted worldwide, therefore ...
(Date:5/21/2015)... 2015 Research and ... addition of the "North American Joint ... Replacement, Elbow Replacement, Hip Replacement, Knee Replacement, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... valued at $4,470.9 million in 2014 and ...
Breaking Medicine Technology:2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... , CHICAGO , July 30 ... equity firm focused exclusively on health care, announced today ... (MSD).  Headquartered in Stoughton, Massachusetts , MSD ... biomedical services and technology solutions to the growing home ...
... , CATANIA, Italy , July 30 ... European research project today announced details of the ... three-year ENIAC (European Nanoelectronics Initiative Advisory Council) project ... 3D-imaging platforms by focusing on the diagnosis and ...
Cached Medicine Technology:Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 2Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 3Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 4European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 2European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 3
(Date:5/22/2015)... 22, 2015 The dentist ... announces that they are now offering complimentary consultations ... dental treatments. At consultations, patients can discuss their ... what certain treatments can achieve and whether alternative ... this initial appointment. If treatments are chosen, patients ...
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened for business ... have concentrated their focus to working with over 300 ... this growth and their goals to better serve their ... Cleveland, Ohio, Houston, Texas and now Dallas, Texas. ... dental start ups, orthodontic practices, pediatric dental practices, endodontic ...
(Date:5/22/2015)... In efforts to offer full and ... particular muscles stretches has been a large focus over ... now complete, Chunk Fitness envisions a mid-June launch of ... and released at a later point in time. The ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness was ...
(Date:5/21/2015)... 2015 World Patent Marketing, a vertically ... Troll Motor Guide, a boat patent that aims to ... recreational boating industry has reached an annual revenue of ... Director of World Patent Marketing , "Americans are ... continued steady growth of seven percent in new sales ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... Va., March 9 CEL-SCI Corporation (NYSE Alternext ... into an exclusive licensing agreement with Byron Biopharma ... exclusive license to market and distribute the Company,s ... Africa (the "Territory"). CEL-SCI already has existing ...
... Ky., March 9 VirtualHealth Technologies, Inc. (OTC Bulletin ... Envoii Healthcare, LLC has changed it,s name to Secure ... Security products. According to Jim Renfro, VHGI President "This ... effort to demonstrate our company,s commitment on growing our ...
... nerves, researchers say , , MONDAY, March 9 (HealthDay News) -- ... a safe, effective and less invasive way to relive the ... Small spongy discs normally act as shock absorbers between the ... break, putting pressure on spinal cord nerves. The standard treatments ...
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... will be presenting at the upcoming Cowen and Company ... on Tuesday, March 17, 2009 at 8:45 a.m. Eastern ... Marriott Copley Place in Boston, MA, March 16-19, 2009.Individuals ...
... Time Declared ,Vitamin D Day, to Remind Americans to Get ... get ready to change our clocks for Daylight Saving Time, ... Vitamin D Day to raise awareness of the important role ... make our own vitamin D when the ultraviolet rays of ...
... and Easier TreatmentsOTTAWA, March 9 /PRNewswire-FirstCall/ - ... isotopes and radiopharmaceuticals, today announced the launch ... Yttrium-90 Microsphere (Y-90), a targeted internal radiation ... cancer. The enhancements to the administration system ...
Cached Medicine News:Health News:CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa 2Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 2Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 3Health News:Ozone/Oxygen Shot Helps Heal Herniated Disk 2Health News:Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 2Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 3Health News:Vitamin D Deficiency Has Emerged as a Silent Epidemic 4Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 2Health News:MDS Nordion Launches Improved TheraSphere(R) Administration System for Physicians 3
... ENA Profile-6 ELISA test system is a ... antibodies to Jo-1, Sm, Sm/RNP, SSA, SSB, ... according to the directional insert, the results ... the diagnosis and treatment of autoimmune connective ...
Inquire...
... The K-ASSAY Microalbumin Urine Controls ... to use liquid requiring no ... prepared from human urine, fortified ... albumin and creatinine. Preservatives including ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: